The Long-Term Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Among Illicit Drug Users: A Modeling Study

被引:9
|
作者
Javanbakht, Mehdi [1 ,2 ]
Mirahmadizadeh, Alireza [3 ]
Mashayekhi, Atefeh [4 ]
机构
[1] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen, Scotland
[2] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] Shiraz Univ Med Sci, HIV AIDS Res Ctr, Shiraz, Iran
[4] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Hlth Management & Econ Res Ctr, Tehran, Iran
关键词
Hepatitis C Virus; Iran; Methadone Maintenance Treatment; Quality Adjusted Life Years; Illicit Drug Users; Markov Model; HUMAN-IMMUNODEFICIENCY-VIRUS; COST-EFFECTIVENESS; SEXUAL TRANSMISSION; PROSPECTIVE COHORT; INJECT DRUGS; RISK-FACTORS; INFECTION; PREVALENCE; IMPACT; METAANALYSIS;
D O I
10.5812/ircmj.13484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic infection with hepatitis C virus (HCV) is increasingly recognized as a major global health problem. Illicit injection drug use is an important risk factor for the rising hepatitis C virus (HCV) prevalence in IR Iran. Objectives: The objective of this study was to determine the long-term effectiveness (total quality adjusted life years (QALYs) gained) of methadone maintenance treatment (MMT program) in prevention of HCV infection among injecting drug users (IDUs). Materials and Methods: A number of Markov models were developed to model morbidity and mortality among IDUs. The input data used in modeling were collected by a self-reported method from 259 IDUs before registration and one year after MMT and also from previous studies. One way and probabilistic sensitivity analyses were done to show the effects of uncertainty in parameters on number of life years and QALYs saved. The expected consequences were estimated using a life-time time horizon for the two strategies including implementation and not implementation of the MMT program. Results: Our model estimated that total number of discounted life years lived per IDU with and without the MMT program would be 5.15 (5.05- 5.25) and 4.63 (4.42- 4.81),respectively. The model also estimated that total number of discounted QALYs lived per IDU with and without the MMT program would be 4.11 (3.86-4.41) and 2.45 (2.17 - 2.84). Simulation results indicated that all differences in life years and QALYs lived between the two strategies were statistically significant (p < 0.001). Based on our model, total discounted life years and QALYs saved in a cohort of 1000 IDUs were 1790 (1520 - 2090) and 1590 (1090-2090), respectively. Conclusions: Considering the high prevalence of illicit injecting drug use in Iran and MMT effectiveness in prevention of HCV infection, it is necessary to develop MMT centers at regional and national levels.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study
    Zou, Xia
    Ling, Li
    Zhang, Lei
    BMJ OPEN, 2015, 5 (08):
  • [42] Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
    Philip, Bruggmann
    Sarah, Blach
    Pierre, Deltenre
    Jan, Fehr
    Roger, Kouyos D.
    Daniel, Lavanchy
    Beat, Muellhaupt
    Andri, Rauch
    Homie, Razavi
    Patrick, Schmid
    David, Semela
    Marcel, Stoeckle
    Franco, Negro
    SWISS MEDICAL WEEKLY, 2017, 147
  • [43] Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy
    Taylor, Lynn E.
    Bowman, Sarah E.
    Chapman, Stacey
    Zaller, Nickolas
    Stein, Michael D.
    Cioe, Patricia A.
    Maynard, Michaela A.
    McGovern, Barbara Hedgis
    DRUG AND ALCOHOL DEPENDENCE, 2011, 116 (1-3) : 233 - 237
  • [44] Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon
    Mahfoud, Ziyad
    Kassak, Kassem
    Kreidieh, Khalil
    Shamra, Sarah
    Ramia, Sami
    VIROLOGY JOURNAL, 2010, 7
  • [45] Hepatitis C Virus-Related Knowledge and Willingness to Receive Treatment Among Patients on Methadone Maintenance
    Zeremski, Marija
    Dimova, Rositsa B.
    Zavala, Roberto
    Kritz, Steven
    Lin, Melissa
    Smith, Bryce D.
    Zibbell, Jon E.
    Talal, Andrew H.
    JOURNAL OF ADDICTION MEDICINE, 2014, 8 (04) : 249 - 257
  • [46] Recommendations for the management of hepatitis C virus infection among intravenous drug users
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 111
  • [47] Treatment as prevention for hepatitis C virus in the Middle East and North Africa: a modeling study
    Ayoub, Houssein H.
    Mahmud, Sarwat
    Chemaitelly, Hiam
    Abu-Raddad, Laith J.
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [48] Improving entry to methadone maintenance among out-of-treatment injection drug users
    Booth, RE
    Corsi, KF
    Mikulich, SK
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2003, 24 (04) : 305 - 311
  • [49] Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support
    Grebely, Jason
    Knight, Elizabeth
    Genoway, Krista A.
    Viljoen, Mark
    Khara, Milan
    Elliott, Doug
    Gallagher, Lesley
    Storms, Michelle
    Raffa, Jesse D.
    DeVlaming, Stanley
    Duncan, Fiona
    Conway, Brian
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (03) : 270 - 277
  • [50] Epidemiology of syphilis infection among drug users at methadone maintenance treatment clinics in China: systematic review and meta-analysis
    Wang, Bing-xiang
    Zhang, Li
    Wang, Yu-jie
    Yan, Jun-wei
    Wan, Ya-nan
    Peng, Wen-jia
    Wang, Jing
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (08) : 550 - 558